LOGICBIO THERAPEUTICS INC. - COMMON STOCK (LOGC)
(Delayed Data from NSDQ)
$14.61 USD
+0.80 (5.79%)
Updated May 3, 2019 04:00 PM ET
After-Market: $14.21 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[LOGC]
Reports for Purchase
Showing records 21 - 40 ( 50 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Healthcare- Yas'' Weekly Recap of Our Key Notes and Upcoming Events
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Part 3: Expert Call Recap for 2019 in Rare Disease
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Part 2: "Must-See" Companies at JPM (Mkt. Cap. $100M-$499M) With 1Q20 Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
3Q19 - The Gifts Are Piled High for LOGC in 4Q19
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Takeaways from our Expert Call with Dr. Ian Alexander
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Mirror, Mirror on the Gene Therapy Wall, Why Is GeneRide Safest Of All?
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: The More Analysis, The Merrier, Especially When Data-Driven
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y